Head of Early-Stage R&D Helaina Inc. New York City, NY, United States
Present methods for harnessing the health benefits of bioactive glycoproteins naturally occurring in milk are hampered by greenhouse gas-intensive processes, demanding substantial milk volumes to yield minimal quantities. Furthermore, the functional equivalence to human counterparts is lacking. At Helaina, we have developed a platform technology facilitating the production of human glycoproteins sourced from sustainable sources by leveraging the power of precision fermentation. Our focus lies in replicating the intricate glycan decorations mimicking human core structures. This nuanced approach, often neglected in prior food applications utilizing precision fermentation, stands as the optimal route for securing regulatory approval of human proteins in the food industry.